Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

501-94-0Metoprolol EP Impurity G

● In Stock

Catalogue No.:	VL103002
CAS No.:	501-94-0
Mol. Formula:	C8H10O2
Mol. Weight:	138.16

Request a quote

Add to RFQ list

Additional information on CAS 501-94-0

Parent drug

Metoprolol

IUPAC Name

2-(4-Hydroxyphenyl)ethanol

Synonyms

Metoprolol Succinate EP Impurity G; Metoprolol Tartarate EP Impurity G; 4-(2-hydroxyethyl)phenol; Tyrosol; 4-Hydroxy-benzeneethanol; 2-(4-Hydroxyphenyl)ethanol; 2-(4-Hydroxyphenyl)ethyl Alcohol; NSC 59876; Metoprolol Impurity G; Metoprolol EP Impurity G

Description

Also known as Metoprolol Succinate EP Impurity G, Metoprolol Tartarate EP Impurity G, 4-(2-hydroxyethyl)phenol, Tyrosol or 2-(4-Hydroxyphenyl)ethanol, Metoprolol has been given FDA approval to treat hypertension, atrial fibrillation/flutter, myocardial infarction, and angina. Supraventricular tachycardia and thyroid storm are examples of off-label applications. There are formulations for oral and intravenous administration. Oral formulations for both immediate and prolonged release are available. The use of beta-blockers in the treatment of the aforementioned disorders is debatable. Additionally, there is conflicting evidence regarding the best beta-blocker to use in treating a given condition. Metoprolol's mechanism of action, adverse event profile, pharmacology, monitoring, and significant interactions will be highlighted in this activity, which is important for members of the interprofessional team treating patients with disorders where it is clinically useful.

References

Morris, J., & Dunham, A. (2022, July 11). Metoprolol. Retrieved August 23, 2022, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK532923/ â€Œ